US reports more cases of vaccine allergy, CDC monitoring safety of Pfizer, Moderna doses
3 years, 11 months ago

US reports more cases of vaccine allergy, CDC monitoring safety of Pfizer, Moderna doses

India Today  

With the US rolling out two major coronavirus vaccines Pfizer and Moderna vaccines for its population, several cases of vaccine allergies have been reported from across the country. According to reports in the US media, CDC has said 28 cases of anaphylaxis, a severe allergic reaction, have been detected after these people were administered the Pfizer Covid-19 vaccine. The difference in allergic reactions to Pfizer and Moderna vaccines are being attributed to the time span between authorisation given to the two vaccine shots. The authorities, however, said that even with 11 cases of allergic reactions per 1 million vaccinations, the Pfizer vaccine can be called safe.

Cases Cdc Vaccine Moderna Pfizer Reactions Allergic  cdc  cases  million  vaccine  allergic  moderna  anaphylaxis  reported  reports  doses  monitoring  vaccines  allergy  reactions  safety  pfizer

History of this topic

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
1 year, 3 months ago

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots

India Today  

The U.S. Food and Drug Administration on Monday authorized updated Covid-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the coronavirus, paving the way for the launch later this week of a fall vaccination campaign. Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available …

Should you get the new COVID booster? The CDC is about to decide
1 year, 3 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

US renews push for COVID boosters as data show they protect
2 years, 1 month ago

US renews push for COVID boosters as data show they protect

Associated Press  

Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who haven’t — at least for now, U.S. health officials said Tuesday. Speaking at a White House briefing expected to be his last before he retires from the government at the end of year, Fauci said what “may be the final message I give …

Pfizer, Moderna launch trials to track whether issues arise YEARS after getting their vaccines
2 years, 1 month ago

Pfizer, Moderna launch trials to track whether issues arise YEARS after getting their vaccines

Daily Mail  

Heart inflammation has been the most reported severe side effect of the vaccine Pfizer and Moderna have launched trials to determine whether there are any long-term negative health impacts associated with their Covid vaccines. The same study found that 21 of every million recipients of the original two-dose Pfizer vaccine also suffered the heart issue. A recent Canadian study found …

New vaccines approved, booster campaign to start in September
2 years, 3 months ago

New vaccines approved, booster campaign to start in September

Dutch News  

The new Pfizer and Moderna booster vaccines have been given approval by the European Medicines Agency for over-12s, and another booster campaign is planned for the second half of September. Although the current vaccines protect against serious sickness, they have become less good at protecting against a coronavirus infection due to mutations in the virus, reports NOS. The EMA expects …

New vaccines approved, booster campaign to start in September
2 years, 3 months ago

New vaccines approved, booster campaign to start in September

Dutch News  

The new Pfizer and Moderna booster vaccines have been given approval by the European Medicines Agency for over-12s, and another booster campaign is planned for the second half of September. Although the current vaccines protect against serious sickness, they have become less good at protecting against a coronavirus infection due to mutations in the virus, reports NOS. The EMA expects …

US Approves Pfizer, Moderna Covid-19 Vaccines for Youngest Children
2 years, 6 months ago

US Approves Pfizer, Moderna Covid-19 Vaccines for Youngest Children

News 18  

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries. The agency authorized Moderna’s two-dose vaccine for children aged six months to five years, and three doses of Pfizer’s shots for those between six months and four years …

Covid Vaccines For Children Under-Five Received US FDA Nod
2 years, 6 months ago

Covid Vaccines For Children Under-Five Received US FDA Nod

News 18  

A panel of experts convened by the US Food and Drug Administration unanimously recommended Covid-19 vaccines Wednesday for children under five, the final age group awaiting immunization in most countries. Opening the discussion, senior FDA scientist Peter Marks said that despite studies showing the majority of children have now been infected with the coronavirus, the high rate of hospitalizations among …

US: FDA authorises COVID-19 vaccines for children under 5
2 years, 6 months ago

US: FDA authorises COVID-19 vaccines for children under 5

Al Jazeera  

US President Joe Biden says jabs could be rolled out to that age group as early as next week, pending CDC approval. The US Food and Drug Administration has authorised two COVID-19 vaccines for children under five, opening the door to vaccinating millions of the country’s youngest children once the Centers for Disease Control and Prevention agrees. US President Joe …

US approves first COVID-19 shots for infants and preschoolers
2 years, 6 months ago

US approves first COVID-19 shots for infants and preschoolers

India TV News  

Highlights Pfizer’s shots had previously been the only ones available for those ages Now, U.S. kids under the age of 5 are eligible for the shots Vaccinations could begin as early as Monday or Tuesday U.S. regulators on Friday authorized the first COVID-19 shots for infants and preschoolers, paving the way for vaccinations to begin next week. There’s one step …

America's FDA panel backs Moderna and Pfizer COVID-19 vaccines for children under five. Here's what that means
2 years, 6 months ago

America's FDA panel backs Moderna and Pfizer COVID-19 vaccines for children under five. Here's what that means

ABC  

Children under the age of five could start receiving COVID-19 vaccines in the United States within days, after federal regulators took a major step towards approving shots from Pfizer and Moderna. Kawsar Talaat — an associate professor at Johns Hopkins Bloomberg school of public health, who led one of Pfizer's trial sites — said: "I think it's going to be …

US Panel Recommends Moderna Covid Vaccine for Children Six and Up
2 years, 6 months ago

US Panel Recommends Moderna Covid Vaccine for Children Six and Up

News 18  

A panel of US medical experts on Tuesday recommended the Moderna Covid vaccine for use in children aged six through 17. Formal authorization should soon follow, at which point families will have a second option against the coronavirus, as Pfizer’s vaccine was given the greenlight for teens and younger children last year. After weighing available data, 22 experts convened by …

FDA advisers back Moderna’s COVID-19 vaccine for older kids
2 years, 6 months ago

FDA advisers back Moderna’s COVID-19 vaccine for older kids

Associated Press  

NEW YORK — A government advisory panel Tuesday endorsed a second brand of COVID-19 vaccine for school-age children and teens. Moderna’s COVID-19 vaccine has long been available for adults in the U.S. and elsewhere and more than three dozen countries offer it to older children, too. If the FDA authorizes Moderna’s vaccine for teens and younger children, the Centers for …

Pfizer’s COVID-19 shot appears effective in kids under 5, FDA says
2 years, 6 months ago

Pfizer’s COVID-19 shot appears effective in kids under 5, FDA says

LA Times  

Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for children under 5, a key step toward a long-awaited decision to begin vaccinating the youngest Americans. Kids under 5 are the only group not yet eligible for COVID-19 vaccination in the U.S. Late last week the FDA posted a similar analysis …

US FDA Says Moderna Covid Vaccine Effective For Children Under Five Years
2 years, 6 months ago

US FDA Says Moderna Covid Vaccine Effective For Children Under Five Years

News 18  

US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children were accurate, ahead of a decision next week on whether to authorize two inoculations against the virus in kids aged six months to five years. The Food and Drug Administration, which independently analyzed data from clinical trials …

Marathon US hearings to decide fate of COVID shots for tots
2 years, 6 months ago

Marathon US hearings to decide fate of COVID shots for tots

Associated Press  

Parents anxious to finally vaccinate their youngest children against COVID-19, strap in: A lot is set to happen over the next week. The FDA weighed in late Friday with its own analysis of Moderna’s vaccine, finding the shots appear safe and effective for children as young as 6 months old. MODERNA’S PLAN FOR THE LITTLEST Moderna is seeking FDA clearance …

Moderna says updated COVID shot boosts omicron protection
2 years, 6 months ago

Moderna says updated COVID shot boosts omicron protection

Associated Press  

Moderna’s experimental COVID-19 vaccine that combines its original shot with protection against the omicron variant appears to work, the company announced Wednesday. Moderna’s preliminary study results show people given the combination shot experienced a higher boost in omicron-fighting antibodies than if they just got a fourth dose of the original vaccine. They’re still providing strong protection against severe disease, hospitalization …

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study
2 years, 7 months ago

Fourth Covid-19 vaccine dose provides strong immunity boost: UK study

India TV News  

A fourth dose of the Pfizer or Moderna COVID-19 vaccine is safe and boosts antibody levels, even higher than that of a third dose, according to the latest results from a nationwide study in the UK. The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received …

Covid-19: US FDA approves another Pfizer, Moderna booster dose for age 50 and up
2 years, 8 months ago

Covid-19: US FDA approves another Pfizer, Moderna booster dose for age 50 and up

India Today  

US regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration's decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at least four months after their previous booster. Pfizer had asked the …

What you need to know about COVID vaccines for little kids
2 years, 9 months ago

What you need to know about COVID vaccines for little kids

LA Times  

Ilana Diener plays with her 3-year-old son, Hudson, at home in Commack, N.Y., before an appointment for a Moderna COVID-19 vaccine trial. Moderna intends to seek U.S. authorization for kid-sized shots, releasing early study results Wednesday that suggest the two small doses work in tots younger than 6. Moderna’s results Moderna says tots as young as 6 months developed high …

Moderna says its low-dose COVID shots work for kids under 6
2 years, 9 months ago

Moderna says its low-dose COVID shots work for kids under 6

Associated Press  

Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers, the company announced Wednesday — a development that could pave the way for the littlest kids to be vaccinated by summer if regulators agree. Goodman said the high antibody levels seen in the study “should translate into higher efficacy against severe infections.” Some parents say even a little protection would be …

Moderna says its low-dose COVID shots work for kids under six
2 years, 9 months ago

Moderna says its low-dose COVID shots work for kids under six

Firstpost  

While the study wasn’t large enough to detect very rare side effects, Moderna said the small doses were safe and that mild fevers, like those associated with other common pediatric vaccines, were the main reaction Moderna’s COVID-19 vaccine works in babies, toddlers and preschoolers, the company announced Wednesday – and if regulators agree it could mean a chance to finally …

Side Effects From mRNA Covid Vaccines Usually Mild And Temporary, Large US Study Finds
2 years, 9 months ago

Side Effects From mRNA Covid Vaccines Usually Mild And Temporary, Large US Study Finds

ABP News  

New Delhi: A review of adverse events which take place after vaccination against Covid-19 with mRNA vaccines in the United States confirms that most side effects were mild and decreased substantially after one day, according to a new study published in the The Lancet Infectious Diseases journal. For more than 298 million vaccine doses administered between December 2020 and June …

Moderna asks FDA to authorize 4th COVID-19 dose for all adults
2 years, 9 months ago

Moderna asks FDA to authorize 4th COVID-19 dose for all adults

LA Times  

U.S. health officials currently recommend a primary series of two doses of the Moderna vaccine and a booster dose months later. Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults. In a press release, Moderna said its request for approval for all adults …

CDC backs Moderna COVID-19 shots after full US approval
2 years, 10 months ago

CDC backs Moderna COVID-19 shots after full US approval

Associated Press  

NEW YORK — The Centers for Disease Control and Prevention on Friday continued its endorsement of Moderna’s COVID-19 vaccine for adults, now that U.S. regulators have given the shots their full approval. Tens of millions of Americans have already gotten Moderna shots, following its emergency authorization by the Food and Drug Administration more than a year ago. Under earlier emergency …

Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older
2 years, 10 months ago

Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older

Daily Mail  

Moderna's COVID-19 vaccine has received full approval from the Food and Drug Administration for use in adults in the U.S., the company announced Monday. The Moderna COVID-19 vaccine has received full approval for use in adults from the FDA. Only the first two shots of Moderna's vaccine have received approval, and the booster shot remains available of the emergency use …

U.S. gives full approval to Moderna’s COVID-19 vaccine
2 years, 10 months ago

U.S. gives full approval to Moderna’s COVID-19 vaccine

LA Times  

U.S. regulators have granted full approval to Moderna’s COVID-19 vaccine after reviewing additional data on its safety and effectiveness. Full approval means FDA has completed the same rigorous, time-consuming review for Moderna’s shot as dozens of other long-established vaccines. U.S. health regulators on Monday granted full approval to Moderna’s COVID-19 vaccine, a shot that’s already been given to tens of …

Pfizer, Moderna boosters up to 90% effective against Omicron: CDC
2 years, 11 months ago

Pfizer, Moderna boosters up to 90% effective against Omicron: CDC

Al Jazeera  

Three US studies offer more evidence that third dose of COVID vaccine is highly effective against Omicron. Booster shots of the Pfizer-BioNTech and Moderna vaccines have proven highly effective at preventing Omicron-related hospitalisations, according to three new studies by the US Centers for Disease Control and Prevention. “Americans should get boosters if at least five months have passed since they …

COVID19 vaccines offer lasting protection, claims study
2 years, 11 months ago

COVID19 vaccines offer lasting protection, claims study

India TV News  

New research has found that COVID vaccination offers long-lasting protection from the worst outcomes of infection. The study found that the effectiveness of the Pfizer and Moderna mRNA vaccines in reducing the risk of COVID-19 reached a peak of about 95 per cent two months after the first dose and then gradually declined. At seven months, the Pfizer vaccine dropped …

COVID-19 vaccines offer lasting protection, claims study
2 years, 11 months ago

COVID-19 vaccines offer lasting protection, claims study

India TV News  

A new research has found that COVID-19 vaccination offers long-lasting protection from the worst outcomes of COVID-19. "This is an excellent example of the wonderful research partnership between the Gillings School and NCDHHS, who are working together to generate the evidence base needed to keep our communities safe," said Penny Gordon-Larsen, PhD, Carla Smith Chamblee Distinguished Professor of Global Nutrition …

Moderna says booster appears effective against new COVID variant
3 years ago

Moderna says booster appears effective against new COVID variant

Al Jazeera  

The US biotech company Moderna has said that a booster dose of its COVID-19 vaccine appears to protect against the Omicron variant, according to early laboratory tests. The company said on Monday that its current vaccine would continue to be its “first line of defence against Omicron”, although Moderna still plans to develop a vaccine to protect specifically against Omicron. …

Moderna says its booster shot provides good protection against Omicron
3 years ago

Moderna says its booster shot provides good protection against Omicron

LA Times  

Moderna said that even a half-dose booster of its COVID-19 vaccine increased by 37 times the level of antibodies able to fight the Omicron variant. Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading Omicron variant of the coronavirus. Moderna said lab tests showed that the half-dose booster shot increased by …

CDC recommends Pfizer, Moderna COVID-19 shots over J&J’s
3 years ago

CDC recommends Pfizer, Moderna COVID-19 shots over J&J’s

LA Times  

The Johnson & Johnson shot in rare cases has been found to cause serious blood clots. Most Americans should be given the Pfizer-BioNTech or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday. The unusual clotting problem has caused nine confirmed deaths after J&J vaccinations, while the …

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?
3 years ago

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?

ABC  

The Omicron variant has been generating anxiety across the world since being declared a COVID-19 variant of concern by the World Health Organization over the weekend. According to Westmead Institute virologist Tony Cunningham, scientists around the world — including those in Australia — would be looking at whether protective antibodies in the vaccines were "sufficiently high" to cover this strain. …

US opens COVID boosters to all adults, urges them for 50+
3 years, 1 month ago

US opens COVID boosters to all adults, urges them for 50+

Associated Press  

WASHINGTON — The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise even before millions of Americans travel for the holidays. “I want to make sure we provide as much protection as we can.” …

Pfizer asks FDA to OK COVID-19 booster shots for all adults
3 years, 1 month ago

Pfizer asks FDA to OK COVID-19 booster shots for all adults

LA Times  

Pfizer says its new study concluded that its booster could restore protection against symptomatic COVID-19 infection to nearly 96%. Pfizer’s new study concluded a booster could restore protection against symptomatic infection to about 95%, even as the extra-contagious Delta variant was surging. Researchers tracked any infections that occurred at least a week later, and so far have counted five cases …

Study shows dramatic decline in effectiveness of all three COVID-19 vaccines over time
3 years, 1 month ago

Study shows dramatic decline in effectiveness of all three COVID-19 vaccines over time

LA Times  

A study of 780,000 veterans shows a dramatic decline in effectiveness for all three COVID-19 vaccines in use in the U.S. As the Delta variant became the dominant strain of the coronavirus across the United States, all three COVID-19 vaccines available to Americans lost some of their protective power, with vaccine efficacy among a large group of veterans dropping between …

FDA paves way for Pfizer COVID-19 vaccinations in young kids
3 years, 1 month ago

FDA paves way for Pfizer COVID-19 vaccinations in young kids

Associated Press  

WASHINGTON — The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. “The rationale here is protect your children so that they can get back towards normal life,” said FDA vaccine chief Dr. Peter Marks. “The vaccine will protect them and also protect our communities.” The American Academy of …

FDA advisors back Pfizer’s COVID-19 vaccine for young kids
3 years, 1 month ago

FDA advisors back Pfizer’s COVID-19 vaccine for young kids

LA Times  

A panel of U.S. health advisers endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the country closer to beginning vaccinations for children ages 5 to 11. The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government health advisors on Tuesday endorsed kid-size doses of the shots made by Pfizer and BioNTech …

Moderna says its low-dose COVID-19 shot works for kids 6 to 11
3 years, 2 months ago

Moderna says its low-dose COVID-19 shot works for kids 6 to 11

LA Times  

Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer joins its rival Pfizer in moving toward expanding shots to children. Preliminary results showed vaccinated children developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said in a news release. The …

People who got Covid-19 vaccines were less likely to die from any cause compared to unvaccinated people, study finds
3 years, 2 months ago

People who got Covid-19 vaccines were less likely to die from any cause compared to unvaccinated people, study finds

CNN  

CNN — People who got Covid-19 vaccines were not only less likely to die from the virus, but they were less likely to die from any cause over the following months, researchers reported Friday. That’s in addition to the mounting evidence from other studies showing that the COVID-19 vaccines are effective against COVID-19 infection, serious illness, and death.” The team …

Young men under 30 who receive the Moderna vaccine are more likely to develop heart inflammation
3 years, 2 months ago

Young men under 30 who receive the Moderna vaccine are more likely to develop heart inflammation

Daily Mail  

Young men who receive the Moderna COVID-19 vaccine are at higher risk of developing a rare case of heart inflammation than those who received the Pfizer-BioNTech vaccine, researchers revealed on Thursday. A CDC official presented data that showed young men under the age of 30 who receive the Moderna vaccine have experienced a slight uptick in myocarditis and pericarditis cases. …

CDC endorses booster doses of Moderna and Johnson & Johnson vaccines, says mix and match is fine
3 years, 2 months ago

CDC endorses booster doses of Moderna and Johnson & Johnson vaccines, says mix and match is fine

CNN  

CNN — US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky endorsed recommendations for booster doses for Moderna’s and Johnson & Johnson’s coronavirus vaccines Thursday, allowing millions more Americans to begin getting booster shots. They include people: • 65 years and older • Age 18+ who live in long-term care settings • Age 18+ who have underlying medical …

Pfizer-BioNTech report high efficacy of COVID boosters in study
3 years, 2 months ago

Pfizer-BioNTech report high efficacy of COVID boosters in study

Al Jazeera  

The companies say phase III trial data show booster shot of COVID-19 vaccine was 95.6 percent effective against the disease. American pharmaceutical company Pfizer and its partner BioNTech have said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the coronavirus, including the Delta variant. They said a trial of 10,000 …

U.S. FDA authorises 'mix and match' COVID-19 vaccine; backs Moderna, J&J boosters
3 years, 2 months ago

U.S. FDA authorises 'mix and match' COVID-19 vaccine; backs Moderna, J&J boosters

The Hindu  

U.S. regulators on October 20 signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially. The Food and Drug Administration’s decisions mark a big step toward expanding the U.S. booster campaign, which began with …

FDA panel endorses lower-dose Moderna COVID-19 shot for booster
3 years, 2 months ago

FDA panel endorses lower-dose Moderna COVID-19 shot for booster

The Hindu  

U.S. health advisers said on October 14 that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk …

FDA Panel Endorses Moderna COVID-19 Vaccine Booster Shots For Seniors, High-Risk Groups
3 years, 2 months ago

FDA Panel Endorses Moderna COVID-19 Vaccine Booster Shots For Seniors, High-Risk Groups

Huff Post  

LOADING ERROR LOADING U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. Moderna is seeking FDA clearance for a booster used just like Pfizer’s: For people 65 and older, or adults with other health problems, jobs or living situations that put them at increased risk …

US FDA advisers weigh case for booster shots of Moderna Covid-19 vaccine
3 years, 2 months ago

US FDA advisers weigh case for booster shots of Moderna Covid-19 vaccine

Hindustan Times  

Israel health officials on Thursday said booster doses of the Pfizer-BioNTech Covid-19 vaccine improved severe disease protection in people aged 40 and older, in presentations made to U.S. scientists discussing a booster dose of Moderna's vaccine. Moderna is seeking approval of a booster shot that includes 50 micrograms of vaccine, half of strength of its regular dose but still higher …

US FDA advisers back Moderna’s booster jab for COVID
3 years, 2 months ago

US FDA advisers back Moderna’s booster jab for COVID

Al Jazeera  

With 66 million American adults still unvaccinated, President Biden is pushing for emergency approvals of booster jabs. The FDA’s Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend the booster shot on Thursday and will mull approving an additional dose of the Johnson & Johnson’s vaccine on Friday. Speaking before the panel’s recommendation, President Joe Biden, who is …

FDA panel recommends authorization of Moderna booster shots
3 years, 2 months ago

FDA panel recommends authorization of Moderna booster shots

LA Times  

A vial of the Moderna COVID-19 vaccine at a hospital in Denver. U.S. health advisors said Thursday that some Americans who received the Moderna vaccine should get a half-dose booster. U.S. health advisors said Thursday that some Americans who received Moderna’s COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus. …

Discover Related